Diagnostics & Testing

DeciBio provides strategy consulting and market intelligence services to life sciences companies focused on precision medicine, including research tools, clinical diagnostics, pharma, and biotech. They offer capabilities such as competitive analysis, data analytics, KOL identification, market landscaping, and product specification mapping. With deep expertise in clinical diagnostics and proprietary databases, DeciBio supports global clients across North America, Europe, Asia, Africa, and Australia.

10x Genomics provides single-cell and spatial transcriptomics technologies, including Chromium systems for high-throughput gene expression profiling and GEM-based barcoding of thousands of cells. Their Visium and Xenium platforms enable spatial biology analysis with whole transcriptome profiling and subcellular RNA localization. These tools support pharma R&D in cell heterogeneity, biomarker discovery, immune profiling, and AI-driven drug development.

DiaCarta provides highly sensitive qPCR-based assays and technologies like XNA clamping and SuperbDNA for detecting rare mutations in oncology, including lung, colorectal, bladder, and pan-cancer panels. Their solutions support liquid biopsy, FFPE samples, and work on existing lab instruments for rapid, cost-effective diagnostics. They offer CLIA-certified services and research-use-only testing for precision medicine applications.

DiaSorin is a world leader in laboratory diagnostics, specializing in immunodiagnostics and molecular diagnostics for detecting antibodies and antigens. They offer fast, accurate, and cost-effective solutions including targeted in vitro diagnostic kits, reagents, multiplexing technologies, and instruments for respiratory testing and other applications. DiaSorin provides specialized systems, techniques, and tools to empower laboratories worldwide with reliable data and workflow efficiency.

EKF Diagnostics develops and manufactures point-of-care in-vitro diagnostic devices, tests, and analyzers for rapid clinical decisions, including glucose, lactate, hemoglobin, and hematocrit measurement. Their EKF Life Sciences division produces diagnostic enzymes and custom biomolecules via bacterial fermentation for pharmaceuticals, medical diagnostics, and industry. Products are distributed to over 120 countries from facilities in the USA and Germany, supported by EKF Link middleware for data management and connectivity to LIMS/HIS systems.

Endometrics develops non-invasive diagnostic tests for endometriosis and women's health conditions using menstrual blood as an organ-proximal liquid biopsy. The company integrates tissue-derived biomarker discovery, proprietary bioinformatics, and at-home sampling for scalable molecular diagnostics of gynecologic diseases. Endometrics won first prize in the NIH RADx Tech ACT ENDO Challenge for its clinically graded test collected at home.

Eremid Genomic Services provides customized contract research services in genomics and bioinformatics for AgBiotech, Food & Nutrition, and Human Health organizations. Their CLIA-certified and CAP-accredited laboratory supports research and clinical genomics projects, including long-read HiFi sequencing with PacBio Revio, microbiome analysis, cancer research, and immuno-oncology. Services cover genomics, transcriptomics, epigenetics, and data interpretation from concept to delivery.

EUROIMMUN, part of Revvity, is an international provider of medical laboratory diagnostic products and automation solutions for autoimmune, infectious disease, allergy, endocrinology, and neurological testing. The company offers indirect immunofluorescence assays (IFA), ELISAs, immunoblots, chemiluminescence immunoassays (ChLIA), and PCR-based systems spanning over 1,000 diagnostic parameters. With more than 3,400 employees across 17 countries, EUROIMMUN serves laboratories in over 140 countries and provides state-of-the-art instruments and software for efficient automation of routine diagnostics.

Exagen Inc. is a CAP-accredited and CLIA-certified rheumatology specialty laboratory providing advanced autoimmune disease diagnostics through its AVISE testing platform. The company offers comprehensive biomarker testing for diagnosis, prognosis, and monitoring of systemic lupus erythematosus (SLE), rheumatoid arthritis, and other connective tissue diseases, featuring proprietary Cell-Bound Complement Activation Products (CB-CAPs) technology and over 30 clinically relevant biomarkers.

biomodal offers the duet multiomics solution, +modC, which simultaneously captures genetic and epigenetic data (A, C, G, T, 5mC, 5hmC) from a single low-volume DNA sample (as low as 5ng) in one sequencing run. This technology enables comprehensive analysis for applications in cancer research, precision medicine, and disease biology studies. Formerly Cambridge Epigenetix, biomodal provides tools that enhance accuracy, efficiency, and depth of biological insights for life sciences and pharma R&D.

GeneDx provides comprehensive genetic testing including whole exome sequencing, whole genome sequencing, and targeted panels for diagnosing rare and complex conditions in pediatric and adult populations. For biopharma, GeneDx offers GeneDx Infinity™, a genomic data platform with the largest rare disease dataset, over 2.5M genetic tests, 1M+ exomes and genomes, and deep phenotypic data linked to claims for real-world evidence. This supports drug discovery, development, and patient journey analysis in life sciences and pharma.

Oxford Gene Technology (OGT) is a leading global provider of diagnostic genomic solutions and biomarker discovery platforms for precision medicine. The company offers comprehensive NGS panels, cytogenetics arrays, FISH probes, and microarray services designed for cancer detection, inherited genetic disease identification, and clinical trial support. OGT serves pharmaceutical, diagnostic, and research organizations with FDA-cleared and IVDR-certified products across genomics, biomarkers, and licensing divisions.

Genomic Testing Cooperative (GTC) provides comprehensive DNA and RNA next-generation sequencing (NGS) for solid tumors and hematologic malignancies, including liquid biopsy options. Their cooperative model partners with labs, hospitals, and oncology practices to share resources, reduce costs, and enable faster turnaround times of 5-10 days using AI-driven informatics. Tests are Medicare-covered, with reporting including therapy recommendations and clinical trial matches.

Genomics England partners with the NHS to provide whole genome sequencing for patients with cancer and rare diseases, enabling precise diagnostics and treatment. They offer a secure Research Environment where de-identified genomic and clinical data supports biotech and academic researchers in discovering new therapies. Their bioinformatics tools and platforms drive genomic research, contributing to the UK Life Sciences Vision.

Biognosys provides next-generation mass spectrometry-based proteomics contract research services to accelerate pharma and biotech drug discovery, development, and clinical trials. Key offerings include unbiased protein expression profiling from tissues and biofluids, drug target identification and validation, biomarker discovery, and custom panels for absolute quantification using proprietary HRM-MS and PQ500 technologies. They have expanded into multiomics with biocrates metabolomics and lipidomics services available in Europe and the US.

Pharmagene Discovery Services is a contract research organisation specializing in human tissue-based drug discovery and preclinical research. Operating since 1996 from Cambridge, UK, the company provides customized assay development, spatial biology analysis, target validation, biomarker discovery, and biotherapeutic safety testing using consented human biospecimens. Their services support pharmaceutical, biotechnology, and patient foundation clients throughout the drug discovery and development pipeline.

INDICAL Bioscience is a global biotech company specializing in molecular and immunological veterinary diagnostic solutions for livestock, poultry, and companion animals. They offer innovative products, workflows, qPCR assays, and services like ScreenFloX® for early pathogen detection via air sampling to monitor health, prevent diseases, and improve animal welfare. With three decades of experience, INDICAL provides complete diagnostic protocols, expert support, and an online shop for reliable testing kits.

Illumina provides next-generation sequencing (NGS) and microarray technologies for life science research, translational genomics, and molecular diagnostics. Their sequencing by synthesis (SBS) platforms offer high-throughput, scalable solutions supporting applications in cancer research, reproductive health, microbiology, and more. These tools enable pharmaceutical R&D by accelerating genomic discoveries and improving workflows through integrated technology solutions.

Serimmune is an immune intelligence company providing advanced serum antibody profiling through its proprietary SERA (Serum Epitope Repertoire Analysis) platform. The company combines bacterial display peptide library technology, next-generation sequencing, and machine learning to deliver comprehensive immune response mapping for diagnostics, vaccine development, and therapeutic research. Serimmune's capabilities include precision Lyme disease diagnostics, Long COVID immune profiling, and pathogen exposure assessment from minimal serum samples. Now part of Infinity Bio, the company continues expanding its epitope profiling and antibody reactome services for pharmaceutical and research applications.

Immunexpress develops molecular diagnostics for rapid sepsis detection by analyzing host immune response gene expression from whole blood. Their flagship product, SeptiCyte RAPID, is a fully automated cartridge compatible with the Biocartis Idylla platform, delivering results in about one hour to differentiate sepsis from non-infectious inflammation. This technology supports clinicians in early triage and treatment decisions, improving patient outcomes and reducing healthcare costs.

Biohit Healthcare, part of Finnish biotech company Biohit Oyj, develops and markets diagnostic products for gastrointestinal diseases, including the blood-based GastroPanel test for Helicobacter pylori infection and atrophic gastritis. They offer point-of-care quick tests, biopsy tests for lactose intolerance and H. pylori, and automated immunoassay analyzers for EIA assays. Solutions support early detection of stomach cancer risks and triage for gastroscopy in clinical settings.

Inocras is a bioinformatics-led company providing whole genome sequencing and precision oncology solutions for cancer diagnosis and treatment selection. Their platforms include CancerVision for comprehensive genomic profiling and MRDVision for minimal residual disease detection with ultra-high sensitivity (1 ppm limit of detection). The company delivers actionable genomic insights, clinical trial matching, and germline/somatic variant analysis to support precision health and targeted therapy selection.

InterVenn Biosciences offers GlycoVision™, an AI-powered glycoproteomics platform using LC-MS/MS for high-throughput biomarker discovery from serum or plasma samples. The platform enables site-specific protein glycosylation analysis for precision medicine applications in oncology, diagnostics, and drug development. Key products include the GlycoKnow™ Ovarian cancer liquid biopsy test, with partnerships expanding clinical workflows and global lab facilities.

n6 Tec provides the iconPCR platform, a benchtop thermocycler with 96 independently controlled wells for precise DNA amplification in next-generation sequencing workflows. It features AutoNorm technology for real-time per-well monitoring, adaptive cycling, and automated normalization, reducing artifacts and batch effects while using existing reagents. The system supports applications like RNA-seq, metagenomics, whole genomes, and single-cell analysis, enabling scalable, high-quality genomic data preparation.